|
|
Previous Article | Table of Contents | Next Article 
Blood, Vol. 96 No. 2 (July 15), 2000:
pp. 610-617
Genetic defect in human X-linked agammaglobulinemia impedes a
maturational evolution of pro-B cells into a later stage of pre-B cells
in the B-cell differentiation pathway
Keiko Nomura,
Hirokazu Kanegane,
Hajime Karasuyama,
Satoshi Tsukada,
Kazunaga Agematsu,
Gyokei Murakami,
Satoru Sakazume,
Masahiro Sako,
Rieko Tanaka,
Yoshinori Kuniya,
Takuya Komeno,
Shigehiko Ishihara,
Keizo Hayashi,
Tadamitsu Kishimoto, and
Toshio Miyawaki
From the Department of Pediatrics at the Faculty of
Medicine, Toyama Medical and Pharmaceutical University, the Toyama Red
Cross Hospital, and the Kamiichi Welfare Hospital, Toyama, Japan; the
Department of Immunology, The Tokyo Metropolitan Institute of Medical
Science, Tokyo, Japan; the Department of Pediatrics, Dokkyo Medical
Koshigaya School, Saitama, Japan; the Department of Pediatrics at Osaka
City General Hospital and Kashiwara Municipal Hospital and the
Department of Molecular Medicine, Osaka University Medical
School, Osaka, Japan; the Department of Pediatrics, Shinshu
University School of Medicine, Matsumoto, Japan; the Japanese
Red Cross Society Wakayama Medical Center, Wakayama, Japan;
the Department of Pediatrics, NTT Sapporo Hospital, Sapporo,
Japan; and the Division of Hematology, Institute of Clinical Medicine,
University of Tsukuba, Tsukuba, Japan.
Surrogate light chains ( 5/VpreB) are selectively
expressed in early precursors of B cells. B-cell defects in
X-linked agammaglobulinemia (XLA) are caused by mutations in the
gene for Bruton's tyrosine kinase. To elucidate the nature of early
B-lineage cells in bone marrow (BM), samples from 13 XLA patients
and 24 healthy controls of different ages were comparatively
analyzed using an antihuman VpreB monoclonal antibody. Expression of
surrogate light (SL) and µ-heavy chains were examined after cell
membrane permeabilization because they are mainly expressed in the
cytoplasm of early B-lineage cells. A flow cytometric analysis of
normal BM identified 5 discrete cell types of B cells:
µ SL++ (pro-B [B-cell progenitor]),
µlowSL++ (pre-B1a),
µlowSL+ (pre-B1b),
µlowSL (pre-B2), and
µhighSL (B). The large cells,
presumably in cycling states, were enriched in pre-B1a cells. The
frequencies of B-lineage cells in BM were higher in young children, and
declined with advancing age. In contrast, XLA showed a profound
reduction in BM B-lineage cells. In XLA BM, an expansion of pro-B cells
with some small pre-B1a cells was marked, but other cells were
negligible. These observations illustrate a B-cell maturation defect in
XLA as well as a normal human B-cell differentiation pathway. The
results suggest that the genetic defect in XLA may impede the evolution
of pro-B cells beyond the earlier pre-B stage into the later stage of
pre-B cells in B-cell development.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
E. Arana, N. E. Harwood, and F. D. Batista
Regulation of integrin activation through the B-cell receptor
J. Cell Sci.,
July 15, 2008;
121(14):
2279 - 2286.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Rajaiya, M. Hatfield, J. C. Nixon, D. J. Rawlings, and C. F. Webb
Bruton's Tyrosine Kinase Regulates Immunoglobulin Promoter Activation in Association with the Transcription Factor Bright
Mol. Cell. Biol.,
March 15, 2005;
25(6):
2073 - 2084.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. W. Yu, R. S. Tabuchi, R. M. Kato, A. Astrakhan, S. Humblet-Baron, K. Kipp, K. Chae, W. Ellmeier, O. N. Witte, and D. J. Rawlings
Sustained correction of B-cell development and function in a murine model of X-linked agammaglobulinemia (XLA) using retroviral-mediated gene transfer
Blood,
September 1, 2004;
104(5):
1281 - 1290.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Takada, H. Kanegane, A. Nomura, K. Yamamoto, K. Ihara, Y. Takahashi, S. Tsukada, T. Miyawaki, and T. Hara
Female agammaglobulinemia due to the Bruton tyrosine kinase deficiency caused by extremely skewed X-chromosome inactivation
Blood,
January 1, 2004;
103(1):
185 - 187.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Middendorp, G. M. Dingjan, A. Maas, K. Dahlenborg, and R. W. Hendriks
Function of Bruton's Tyrosine Kinase during B Cell Development Is Partially Independent of Its Catalytic Activity
J. Immunol.,
December 1, 2003;
171(11):
5988 - 5996.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Spaargaren, E. A. Beuling, M. L. Rurup, H. P. Meijer, M. D. Klok, S. Middendorp, R. W. Hendriks, and S. T. Pals
The B Cell Antigen Receptor Controls Integrin Activity through Btk and PLC{gamma}2
J. Exp. Med.,
November 17, 2003;
198(10):
1539 - 1550.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. D. Cooper, L. L. Lanier, M. E. Conley, and J. M. Puck
Immunodeficiency Disorders
Hematology,
January 1, 2003;
2003(1):
314 - 330.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. G. Noordzij, S. de Bruin-Versteeg, N. S. Verkaik, J. M. J. J. Vossen, R. de Groot, E. Bernatowska, A. W. Langerak, D. C. van Gent, and J. J. M. van Dongen
The immunophenotypic and immunogenotypic B-cell differentiation arrest in bone marrow of RAG-deficient SCID patients corresponds to residual recombination activities of mutated RAG proteins
Blood,
August 28, 2002;
100(6):
2145 - 2152.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Middendorp, G. M. Dingjan, and R. W. Hendriks
Impaired Precursor B Cell Differentiation in Bruton's Tyrosine Kinase-Deficient Mice
J. Immunol.,
March 15, 2002;
168(6):
2695 - 2703.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. P. Cancro, A. P. Sah, S. L. Levy, D. M. Allman, M. R. Schmidt, and R. T. Woodland
xid mice reveal the interplay of homeostasis and Bruton's tyrosine kinase-mediated selection at multiple stages of B cell development
Int. Immunol.,
December 1, 2001;
13(12):
1501 - 1514.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Martin, D. Wolf-Eichbaum, G. Duinkerken, W. A. Scherbaum, H. Kolb, J. G. Noordzij, and B. O. Roep
Development of Type 1 Diabetes despite Severe Hereditary B-Cell Deficiency
N. Engl. J. Med.,
October 4, 2001;
345(14):
1036 - 1040.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. M. Dingjan, S. Middendorp, K. Dahlenborg, A. Maas, F. Grosveld, and R. W. Hendriks
Bruton's Tyrosine Kinase Regulates the Activation of Gene Rearrangements at the {lambda} Light Chain Locus in Precursor B Cells in the Mouse
J. Exp. Med.,
May 21, 2001;
193(10):
1169 - 1178.
[Abstract]
[Full Text]
[PDF]
|
 |
|
| |